

16 Apr 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260416521284/en/Alkermes-to-Present-Additional-Data-From-Vibrance-1-Phase-2-Study-of-Alixorexton-in-Patients-with-Narcolepsy-Type-1-at-the-American-Academy-of-Neurology-AAN-2026-Annual-Meeting

01 Apr 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260401025174/en/Alkermes-Announces-Initiation-of-Phase-3-Brilliance-Studies-Evaluating-Alixorexton-for-the-Treatment-of-Narcolepsy-Type-1-and-Type-2